KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $375.8 million.

  • Fulgent Genetics' Cash & Current Investments rose 7637.62% to $375.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $375.8 million, marking a year-over-year increase of 7637.62%. This contributed to the annual value of $258.1 million for FY2024, which is 3914.8% down from last year.
  • As of Q3 2025, Fulgent Genetics' Cash & Current Investments stood at $375.8 million, which was up 7637.62% from $292.9 million recorded in Q2 2025.
  • Fulgent Genetics' 5-year Cash & Current Investments high stood at $585.1 million for Q1 2022, and its period low was $213.1 million during Q3 2024.
  • Its 5-year average for Cash & Current Investments is $412.9 million, with a median of $424.2 million in 2023.
  • In the last 5 years, Fulgent Genetics' Cash & Current Investments soared by 173096.7% in 2021 and then plummeted by 5445.32% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Cash & Current Investments stood at $450.5 million in 2021, then rose by 16.81% to $526.2 million in 2022, then fell by 19.4% to $424.2 million in 2023, then plummeted by 39.15% to $258.1 million in 2024, then skyrocketed by 45.6% to $375.8 million in 2025.
  • Its Cash & Current Investments was $375.8 million in Q3 2025, compared to $292.9 million in Q2 2025 and $320.3 million in Q1 2025.